CN113980024A - 一种瑞德西韦中间体化合物的制备方法 - Google Patents
一种瑞德西韦中间体化合物的制备方法 Download PDFInfo
- Publication number
- CN113980024A CN113980024A CN202111180290.9A CN202111180290A CN113980024A CN 113980024 A CN113980024 A CN 113980024A CN 202111180290 A CN202111180290 A CN 202111180290A CN 113980024 A CN113980024 A CN 113980024A
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- preparation
- acid
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 238000006243 chemical reaction Methods 0.000 claims description 64
- 238000000034 method Methods 0.000 claims description 27
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims description 19
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 239000003054 catalyst Substances 0.000 claims description 11
- 239000011230 binding agent Substances 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 9
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 claims description 9
- FBXVOTBTGXARNA-UHFFFAOYSA-N bismuth;trinitrate;pentahydrate Chemical compound O.O.O.O.O.[Bi+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O FBXVOTBTGXARNA-UHFFFAOYSA-N 0.000 claims description 8
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 8
- GFISDBXSWQMOND-UHFFFAOYSA-N 2,5-dimethoxyoxolane Chemical compound COC1CCC(OC)O1 GFISDBXSWQMOND-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 6
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- XPOLVIIHTDKJRY-UHFFFAOYSA-N acetic acid;methanimidamide Chemical compound NC=N.CC(O)=O XPOLVIIHTDKJRY-UHFFFAOYSA-N 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- HZXJVDYQRYYYOR-UHFFFAOYSA-K scandium(iii) trifluoromethanesulfonate Chemical compound [Sc+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F HZXJVDYQRYYYOR-UHFFFAOYSA-K 0.000 claims description 4
- 238000005576 amination reaction Methods 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- PWEBUXCTKOWPCW-UHFFFAOYSA-N squaric acid Chemical compound OC1=C(O)C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-N 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 238000007333 cyanation reaction Methods 0.000 claims description 2
- DHKWOBKCNIDKCO-UHFFFAOYSA-K iron(3+);trichloride;heptahydrate Chemical compound O.O.O.O.O.O.O.[Cl-].[Cl-].[Cl-].[Fe+3] DHKWOBKCNIDKCO-UHFFFAOYSA-K 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000002516 radical scavenger Substances 0.000 claims description 2
- ZEBGLCLVPCOXIV-UHFFFAOYSA-N 7-iodopyrrolo[2,1-f][1,2,4]triazin-4-amine Chemical compound NC1=NC=NN2C(I)=CC=C12 ZEBGLCLVPCOXIV-UHFFFAOYSA-N 0.000 abstract description 9
- 238000000746 purification Methods 0.000 abstract description 8
- 238000004440 column chromatography Methods 0.000 abstract description 7
- 239000000543 intermediate Substances 0.000 abstract description 7
- 238000003912 environmental pollution Methods 0.000 abstract description 4
- 238000005265 energy consumption Methods 0.000 abstract description 3
- 238000010189 synthetic method Methods 0.000 abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 42
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 239000012065 filter cake Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 14
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000003208 petroleum Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 238000001914 filtration Methods 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000000967 suction filtration Methods 0.000 description 7
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 150000007529 inorganic bases Chemical group 0.000 description 5
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- DKACXUFSLUYRFU-UHFFFAOYSA-N tert-butyl n-aminocarbamate Chemical compound CC(C)(C)OC(=O)NN DKACXUFSLUYRFU-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000013557 residual solvent Substances 0.000 description 3
- 238000002390 rotary evaporation Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 238000004537 pulping Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 150000003838 adenosines Chemical class 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229940127073 nucleoside analogue Drugs 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/50—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111180290.9A CN113980024B (zh) | 2021-10-11 | 2021-10-11 | 一种瑞德西韦中间体化合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111180290.9A CN113980024B (zh) | 2021-10-11 | 2021-10-11 | 一种瑞德西韦中间体化合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113980024A true CN113980024A (zh) | 2022-01-28 |
CN113980024B CN113980024B (zh) | 2024-05-31 |
Family
ID=79738013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111180290.9A Active CN113980024B (zh) | 2021-10-11 | 2021-10-11 | 一种瑞德西韦中间体化合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113980024B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115124539A (zh) * | 2022-07-29 | 2022-09-30 | 河南豫辰药业股份有限公司 | 一种7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的制备方法 |
CN115873002A (zh) * | 2022-12-09 | 2023-03-31 | 上海药坦药物研究开发有限公司 | 一种瑞德西韦中间体合成方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110092787A (zh) * | 2018-01-31 | 2019-08-06 | 深圳铂立健医药有限公司 | 一种化合物或其药用盐或组合物的制备及应用 |
CN111909153A (zh) * | 2020-04-16 | 2020-11-10 | 山东鲁西药业有限公司 | 7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的合成工艺 |
CN112500417A (zh) * | 2020-12-31 | 2021-03-16 | 山东诚汇双达药业有限公司 | 一种4-氨基吡咯并[2,1-f][1,2,4]三嗪的制备方法 |
CN112625043A (zh) * | 2021-01-22 | 2021-04-09 | 苏州莱克施德药业有限公司 | 一种瑞德西韦中间体三嗪胺衍生物的合成方法 |
CN113248507A (zh) * | 2020-02-09 | 2021-08-13 | 上海茂晟康慧科技有限公司 | 瑞德西韦关键中间体7-卤代吡咯并[1,2-f][1,2,4]三嗪-4-胺的合成方法 |
-
2021
- 2021-10-11 CN CN202111180290.9A patent/CN113980024B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110092787A (zh) * | 2018-01-31 | 2019-08-06 | 深圳铂立健医药有限公司 | 一种化合物或其药用盐或组合物的制备及应用 |
CN113248507A (zh) * | 2020-02-09 | 2021-08-13 | 上海茂晟康慧科技有限公司 | 瑞德西韦关键中间体7-卤代吡咯并[1,2-f][1,2,4]三嗪-4-胺的合成方法 |
CN111909153A (zh) * | 2020-04-16 | 2020-11-10 | 山东鲁西药业有限公司 | 7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的合成工艺 |
CN112500417A (zh) * | 2020-12-31 | 2021-03-16 | 山东诚汇双达药业有限公司 | 一种4-氨基吡咯并[2,1-f][1,2,4]三嗪的制备方法 |
CN112625043A (zh) * | 2021-01-22 | 2021-04-09 | 苏州莱克施德药业有限公司 | 一种瑞德西韦中间体三嗪胺衍生物的合成方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115124539A (zh) * | 2022-07-29 | 2022-09-30 | 河南豫辰药业股份有限公司 | 一种7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的制备方法 |
CN115124539B (zh) * | 2022-07-29 | 2024-02-27 | 河南豫辰药业股份有限公司 | 一种7-碘吡咯并[2,1-f][1,2,4]三嗪-4-胺的制备方法 |
CN115873002A (zh) * | 2022-12-09 | 2023-03-31 | 上海药坦药物研究开发有限公司 | 一种瑞德西韦中间体合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN113980024B (zh) | 2024-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113980024A (zh) | 一种瑞德西韦中间体化合物的制备方法 | |
CN101830946B (zh) | 一种克林霉素磷酸酯的合成方法 | |
CN106699756B (zh) | β内酰胺酶抑制剂阿维巴坦的合成方法 | |
CN106146502A (zh) | 艾代拉里斯的合成方法及制备中间体 | |
CN108395381B (zh) | 1,4-二氨基蒽醌隐色体的合成方法 | |
CN107473943A (zh) | 一种2,6‑二羟基甲苯的制备方法 | |
CN102153609A (zh) | 6-亚甲基单酯的化学合成方法 | |
CN108285471A (zh) | 一种替诺福韦的制备方法 | |
CN110452269A (zh) | 一种利用微反应器制备替诺福韦的方法 | |
CN113292506B (zh) | 一种2-氨基-4,6-二氯-5-硝基嘧啶的制备方法 | |
CN112920054A (zh) | 一种3,3’,4,4’-四氨基联苯的制备方法 | |
CN108794531A (zh) | 一种高纯度替诺福韦酯富马酸盐的制备方法 | |
CN114671859A (zh) | 一种瑞舒伐他汀钙及其中间体的制备方法 | |
CN107602487B (zh) | 2,4,5-三氨基-6-羟基嘧啶甲酸盐、制备方法及应用 | |
CN112778112A (zh) | 一种维生素k3的合成方法及装置 | |
CN106478751B (zh) | 2′,3′-二-o-乙酰-5′-脱氧-5-氟-n4-[(戊氧基)羰基]胞嘧啶核苷的制备方法 | |
CN111004141B (zh) | 一种尼达尼布中间体2-氯-n-甲基-n-(4-硝基苯基)乙酰胺合成新方法 | |
CN103044427B (zh) | 一种药用级腺嘌呤精制纯化方法 | |
CN108383844B (zh) | 2,6-二氯-4,8-二哌啶子基嘧啶并[5,4-d]嘧啶的合成方法 | |
CN113412255B (zh) | 制备4-氨基-5-甲基吡啶酮的方法 | |
WO2019200732A1 (zh) | 一种吡喹酮的新工艺方法 | |
CN109265459B (zh) | 一种黄嘌呤的制备方法 | |
CN106397518B (zh) | 一种氯法拉滨的合成方法 | |
CN112940062B (zh) | 一种16-去氢黄体酮的制备方法 | |
JP4029510B2 (ja) | 5−アミノ−1−ヒドロキシ−2−ナフトエ酸の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240408 Address after: 410200 Huateng Pharmaceutical Industrial Park Auxiliary Workshop at the northwest corner of the intersection of Huacheng Road and Wushan Road, Tongguan Circular Industrial Park, Wangcheng Economic and Technological Development Zone, Changsha, Hunan Applicant after: Changsha innovation Pharmaceutical Industrial Technology Research Institute Co.,Ltd. Country or region after: China Address before: 410013 building E1, Lugu Enterprise Square, Yuelu District, Changsha City, Hunan Province Applicant before: HUNAN HUATENG PHARMACEUTICAL Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |